• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[良性前列腺增生患者接受再次经尿道前列腺电切术时前列腺的组织学特征及其临床意义]

[Histological characteristics of the prostate in men who receive re-TURP for benign prostatic hyperplasia and their clinical significance].

作者信息

Sun Qing-Zeng, Guan Tong-Yu, Qi Jing-Guang, Cao Jing-Yi, Wu Gang, Yang Ning, Cheng Zheng-Yu, Liang Jie, Wang Qian

机构信息

Jiangsu University School of Clinical Medicine, Zhenjiang, Jiangsu 212013, China.

出版信息

Zhonghua Nan Ke Xue. 2010 Feb;16(2):118-22.

PMID:20369693
Abstract

OBJECTIVE

To investigate the pathohistological characteristics of the prostate tissues in patients who receive a second TURP and to evaluate their clinical significance.

METHODS

We collected surgical specimens from 50 cases of TURP (the control group) and another 50 cases of re-TURP (the re-TURP group), detected the expressions of CD34, vascular endothelial growth factor (VEGF) and androgen receptor (AR) in the prostate tissues by immunohistochemistry (S-P), and determined microvessel density (MVD) and the expressions of VEGF and AR. We performed statistical analyses on the results obtained from the specimens of the control group as well as from those of the first and second operations of the re-TURP group.

RESULTS

VEGF and AR expressed in all the specimens. The expressions of VEGF and AR and MVD were significantly higher in the re-TURP group than in the controls (P < 0.05), but showed no significant differences between the first and second operations in the re-TURP group (P > 0.05). Positive correlations were found between the expressions of AR and VEGF, VEGF and MVD, and AR and MVD (r = 0.650, 0.705 and 0.525, P < 0.05).

CONCLUSION

Increased AR, VEGF and MVD in the prostatic tissues may be one of the important causes of recurrence of BPH after TURP, and could be considered as the risk factors for postoperative recurrence and targeted indicators for preventive measures.

摘要

目的

探讨接受二次经尿道前列腺电切术(TURP)患者前列腺组织的病理组织学特征,并评估其临床意义。

方法

收集50例TURP患者的手术标本(对照组)和另外50例再次TURP患者的手术标本(再次TURP组),采用免疫组织化学(S-P法)检测前列腺组织中CD34、血管内皮生长因子(VEGF)和雄激素受体(AR)的表达,并测定微血管密度(MVD)以及VEGF和AR的表达。对对照组标本以及再次TURP组首次和二次手术标本的结果进行统计学分析。

结果

所有标本中均有VEGF和AR表达。再次TURP组VEGF和AR的表达及MVD均显著高于对照组(P < 0.05),但再次TURP组首次和二次手术之间差异无统计学意义(P > 0.05)。AR与VEGF的表达、VEGF与MVD以及AR与MVD之间均呈正相关(r = 0.650、0.705和0.525,P < 0.05)。

结论

前列腺组织中AR、VEGF和MVD升高可能是TURP术后良性前列腺增生(BPH)复发的重要原因之一,可作为术后复发的危险因素及预防措施的靶向指标。

相似文献

1
[Histological characteristics of the prostate in men who receive re-TURP for benign prostatic hyperplasia and their clinical significance].[良性前列腺增生患者接受再次经尿道前列腺电切术时前列腺的组织学特征及其临床意义]
Zhonghua Nan Ke Xue. 2010 Feb;16(2):118-22.
2
Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.接触式激光与经尿道前列腺切除术治疗前列腺轻度或中度增生的良性前列腺增生症的长期疗效比较
Scand J Urol Nephrol. 2003;37(6):487-93. doi: 10.1080/00365590310015769.
3
The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.前列腺癌中血管内皮生长因子-A和环氧合酶-2的血管生成开关:与微血管密度、雄激素受体含量及Gleason分级的相关性
Urol Int. 2011;87(4):464-9. doi: 10.1159/000329289. Epub 2011 Sep 10.
4
Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia.非那雄胺对良性前列腺增生中缺氧和血管生成标志物的影响。
Urology. 2006 Aug;68(2):436-41. doi: 10.1016/j.urology.2006.03.038.
5
Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.前列腺癌组织中血管内皮生长因子(VEGF)、VEGF - C和VEGF受体 - 3表达增加与肿瘤进展相关。
Asian J Androl. 2006 Mar;8(2):169-75. doi: 10.1111/j.1745-7262.2006.00120.x.
6
Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.前列腺干细胞抗原mRNA在术前活检阴性标本中的表达可预测经尿道前列腺电切术治疗良性前列腺增生后是否会发生后续癌症。
Prostate. 2009 Sep 1;69(12):1292-302. doi: 10.1002/pros.20973.
7
Expression of androgen receptor and growth factors in premalignant lesions of the prostate.雄激素受体与生长因子在前列腺癌前病变中的表达
J Pathol. 1998 Oct;186(2):169-77. doi: 10.1002/(SICI)1096-9896(1998100)186:2<169::AID-PATH164>3.0.CO;2-W.
8
[Vinculin and the androgen receptor in prostate cancer: expressions and correlations].[纽蛋白与雄激素受体在前列腺癌中的表达及相关性]
Zhonghua Nan Ke Xue. 2010 Sep;16(9):794-8.
9
Impact of primary hypertension on hematuria of the patients with benign prostatic hyperplasia.原发性高血压对良性前列腺增生患者血尿的影响。
Chin Med J (Engl). 2010 May 5;123(9):1154-7.
10
[Impact of hypertension on angiogenesis in the tissues of benign prostatic hyperplasia].
Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):606-9.

引用本文的文献

1
An immunohistochemical identification key for cell types in adult mouse prostatic and urethral tissue sections.成年小鼠前列腺和尿道组织切片中细胞类型的免疫组织化学鉴定指南
PLoS One. 2017 Nov 16;12(11):e0188413. doi: 10.1371/journal.pone.0188413. eCollection 2017.
2
Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.激素介导的前列腺增生和膀胱出口梗阻小鼠模型的磁共振成像与分子特征分析
Am J Pathol. 2017 Nov;187(11):2378-2387. doi: 10.1016/j.ajpath.2017.07.014. Epub 2017 Aug 18.
3
Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia.
芳香烃受体(AHR)信号在良性前列腺增生中的潜在保护机制。
Differentiation. 2011 Nov-Dec;82(4-5):211-9. doi: 10.1016/j.diff.2011.05.011.